Predicting Relapse in Patients With Medulloblastoma by Integrating Evidence From Clinical and Genomic Features

PURPOSE: Despite significant progress in the molecular understanding of medulloblastoma, stratification of risk in patients remains a challenge. Focus has shifted from clinical parameters to molecular markers, such as expression of specific genes and selected genomic abnormalities, to improve accura...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Tamayo, Pablo, Cho, Yoon-Jae, Tsherniak, Aviad, Greulich, Heidi, Ambrogio, Lauren, Schouten-van Meeteren, Netteke, Zhou, Tianni, Buxton, Allen, Kool, Marcel, Meyerson, Matthew, Pomeroy, Scott L., Mesirov, Jill P.
Formato: Artigo
Lenguaje:Inglês
Publicado: American Society of Clinical Oncology 2011
Materias:
Original Reports
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC3082982/
https://ncbi.nlm.nih.gov/pubmed/21357789
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.2010.28.1675
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares